Design
Review
Key result
Hypertrophic cardiomyopathy (HCM) has a prevalence of 1:500 and is the leading cause of sudden death in athletes in the United States.
Authors
Loading...
Alerts clinicians to HCM screening in athletes; leaves open prospective validation of management for rarer cardiomyopathies.
Key points are not available for this paper at this time.
Ciarambino et al. (2021) studied this question. Hypertrophic cardiomyopathy (HCM) has a prevalence of 1:500 and is the leading cause of sudden death in athletes in the United States.